Newborn Screening for Sickle Cell Disease and Thalassemia
The time has come for a paradigm shift in newborn screening for hemoglobinopathies through the adoption of universal molecular genetic testing.
Authors
- Ashutosh Lal (ORCID: https://orcid.org/0000-0003-0082-3536)
- Jeanne Boudreaux (ORCID: https://orcid.org/0009-0002-4283-4751)
- Angela Snyder (ORCID: https://orcid.org/0000-0002-5149-6355)
- Sujit Sheth (ORCID: https://orcid.org/0000-0002-7640-1244)
- Maa-Ohui Quarmyne
- Brandon K. Attell (ORCID: https://orcid.org/0000-0002-4370-3924)
- Sangeetha Lakshmanan
- M. A. Bender
- Fiona Bock
Institutions
- Seattle Children's Hospital (US)
- Emory University (US)
- Georgia State University (US)
- Cornell University (US)
- Center for Cancer and Blood Disorders (US)
- Aflac (United States) (US)
- Phoenix Children's Hospital (US)
- UCSF Benioff Children's Hospital (US)
- Children's Healthcare of Atlanta (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.0064
- Citations
- 16
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 26.01
Funders
- Centers for Disease Control and Prevention